Prudential Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,725
| Closed | -$22.8K | – | 2709 |
|
|
2022
Q4 | $22.8K | Buy |
25,725
+2,520
| +11% | +$2.23K | ﹤0.01% | 2559 |
|
|
2022
Q3 | $37K | Buy |
23,205
+420
| +2% | +$670 | ﹤0.01% | 2586 |
|
|
2022
Q2 | $45K | Buy |
22,785
+3,670
| +19% | +$7.25K | ﹤0.01% | 2576 |
|
|
2022
Q1 | $45K | Hold |
19,115
| – | – | ﹤0.01% | 2575 |
|
|
2021
Q4 | $89K | Sell |
19,115
-435
| -2% | -$2.03K | ﹤0.01% | 2582 |
|
|
2021
Q3 | $149K | Buy |
19,550
+1,250
| +7% | +$9.53K | ﹤0.01% | 2504 |
|
|
2021
Q2 | $177K | Buy |
18,300
+1,790
| +11% | +$17.3K | ﹤0.01% | 2465 |
|
|
2021
Q1 | $137K | Buy |
16,510
+150
| +0.9% | +$1.25K | ﹤0.01% | 2433 |
|
|
2020
Q4 | $112K | Buy |
16,360
+2,925
| +22% | +$20K | ﹤0.01% | 2388 |
|
|
2020
Q3 | $150K | Buy |
+13,435
| New | +$150K | ﹤0.01% | 2329 |
|